Newsroom / COVID-19 tests

The latest product releases, company news and microsampling industry updates from Neoteryx.

LGC COVID-19 Antibody Assay Processes up to 40,000 Tests Per Day in UK

by Neoteryx, on September 23,2020

LGC COVID-19 Antibody Assay Processes up to 40,000 Tests Per Day in UK

LOS ANGELES and Cambridge, UK — September 2020 — The first commercially available SARS-CoV-2 antibody test in the UK compatible with Neoteryx’s Mitra® Microsampling device for at-home blood collection has …

Read Story
Topics:Remote Blood CollectionViral PathogensCOVID-19 tests

COVID-19 Tests? Consider a Finger-Prick Instead of a Regular Blood Draw

by Neoteryx, on April 29,2020

COVID-19 Tests? Consider a Finger-Prick Instead of a Regular Blood Draw

“COVID-19 testing is top-of-mind for every researcher around the world at present, and effective testing is an important part of every coronavirus pandemic safety plan. Testing can potentially be done …

Read Story
Topics:remote blood samplingCOVID-19 tests
Prev All Posts Next

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs
Neoteryx Experts

Media Contacts
Media Assets
Scientific Research Publications

social media

subscribe to news

Drop us a line

Neoteryx, LLC

421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com

The Mitra Device is a single-use, non-sterile device used as a specimen collector and for the storage and transport of blood or other biological fluids. It is designed to be used by laboratory and healthcare professionals, or end-users as a container to collect and transport blood or other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA and/or other regulatory requirements.
The Mitra Microsampling Device is a FDA listed Class 1 exempt device, CE-IVD self-certified in the UK and EU, a Class I IVD in Australia, and registered with Health Canada. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2019 Neoteryx, LLC. All rights reserved.